Sport & Health Sciences
Exeter, Devon, EX1 2LU, United Kingdom
NCT Number: NCT02984332
The effect of unilateral lower limb immobilisation over one week on muscle atrophy
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Exeter, Devon, EX1 2LU, United Kingdom
This study aims to assess the effect of one week of unilateral leg immobilization on quadriceps muscle volume and muscle protein synthesis rates. Participants wore a leg brace on one leg and ambulated on crutches during the immobilization period. Thirteen healthy young males were recruited to undertake this study.
It is currently understood that unilateral leg immobilization will result in a reduction in muscle size (Berg et al., 1996, Wall et al., 2015) and muscle protein synthesis rates after a period of disuse (de Boer et al., 2015, Glover et al., 2008). Recent research in this area has shown that even short term periods of leg immobilization (i.e. <1 week) will result in reductions in muscle size and muscle protein synthesis rates after the period of disuse (Wall et al., 2015). However we currently do not have detailed information on how muscle disuse affects muscle size and muscle protein synthesis over time during short term disuse (e.g. the first week).
The stable isotope tracer deuterium oxide (D2O) will be applied to assess cumulative muscle protein synthesis between days 0-2, 2-7 and 0-7 of the immobilization period in both the immobilized and non immobilized legs. This will be in-conjunction with bilateral vastus lateralis muscle biopsies before and after 2 and 7 days of immobilization. Furthremore, quadriceps muscle volume was assessed via MRI scans that again occured before and after 2 and 7 days of immobilization. To gain a mechanistic insight on the molecular changes during disuse a custom designed 48 well Taqman low density microarray genecard was applied to assess the transcriptional response on genes involved in muscle protein synthesis and breakdown.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
BMI >18 and <28 no prescription medications or current illness -
Exclusion criteria
BMI <18 and >28 current prescription medication no history of leg injury
Time frame: Days 0, 2 and 7
Quadriceps muscle volume measured via MRI
Time frame: days 0-2, 2-7 and 0-7
The stable isotope tracer deuterium oxide will be used to assess muscle protein synthesis. In conjunction with bilateral vastus lateralis muscle biopsies before and after 2 and 7 days which allow for the calculation of muscle protein synthesis (fractional synthesis rate) between days 0-2, 2-7 and 0-7.
Time frame: Pre and post immobilization
Skeletal muscle one repetition maximum strength was assessed using standard gym equipment
University of Exeter
Other
Short-term Muscle Disuse Induces a Rapid and Sustained Decline in Daily Myofibrillar Protein Synthesis Rates
Acronym: TIME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05156320
Anti-myostatin, Atrophy
Birmingham, Alabama, United States
View Trial DetailsNCT06233825
Anterior Cruciate Ligament Reconstruction, Atrophy
Kingston, Ontario, Canada
View Trial DetailsNCT02912130
Atrophy, Behavior
Liverpool, Merseyside, United Kingdom
View Trial DetailsNCT03921528
Atrophy, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial Details